
The Inhibition Site Test (also known as the Kirby-Bauer Test, Antimicrobial Susceptibility Test, Disk Diffusion Test, or Agar Diffusion Test) is a quick way to evaluate the antimicrobial activity of a material or solution relative to the target microorganism. This is a test that has been used for years and was first developed in the 1950s and then standardized by the World Health Organization in 1961.

As antimicrobial embedded products enter the market, the Inhibition Zone test is used in industry to evaluate the preventive nature against a range of different microorganisms. This test performs best if the antimicrobial material can leak.
Materials tested are typically plastics, textiles, solids, surfaces, liquids, gels, etc. It contains anti-leak antimicrobials embedded in it, as well as antibiotic solutions. The Zone of Inhibition test is a common and basic microbiological test widely used in the medical device and pharmaceutical industries. Clinical guidance for susceptibility testing can be found in CLSI appendix M100. As a well known laboratory in both the Pharmaceutical and Medical Device industries, we are highly experienced in performing Zone of Inhibition testing using a wide variety of microorganisms.
Applicable Standards
EUROLAB, with its highly expert team and internationally accredited laboratories, Inhibition Zone Test It performs all test, analysis, measurement, evaluation and report generation services completely and reliably.
